Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (900.00%)
May 15, 2026, 4:00 PM EST
Anthera Pharmaceuticals Market Cap
Anthera Pharmaceuticals has a market cap or net worth of $2.62 thousand as of May 19, 2026. Its market cap has increased by 9,969.23% in one year.
Market Cap
2.62K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 1, 2010, Anthera Pharmaceuticals's market cap has decreased from 10.98M to 2.62K, a decrease of -99.98%. That is a compound annual growth rate of -40.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.62K | - |
| Dec 31, 2025 | 2.62K | 9,969.23% |
| Dec 31, 2024 | 26.00 | -98.52% |
| Dec 29, 2023 | 1.75K | -33.00% |
| Dec 30, 2022 | 2.62K | -99.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| MetaStat | 3.53K |
| Affimed | 3.28K |
| Rebus Holdings | 3.21K |
| Hemagen Diagnostics | 3.10K |
| OncoVista Innovative Therapies | 2.36K |
| eFFECTOR Therapeutics | 2.35K |